Chemring Group PLC

Director's Dealing • Dec 9, 2025

National Storage Mechanism | Additional information

RNS Number : 8910K

Chemring Group PLC

09 December 2025

9 December 2025

Chemring Group PLC

PDMR share dealing

Chemring Group PLC ("Chemring" or the "Company") announces that it has been notified that Pete Raby, a director of the Company, purchased 6,000 1p ordinary shares in the capital of the Company on 9 December 2025 at an average price of 468.25p per share.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Pete Raby

2

Reason for the notification

a)

Position/status

Director/PDMR

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Chemring Group PLC

b)

LEI

213800U9A54VQJ5P2J41

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

1p ordinary shares

GB00B45C9X44

b)

Nature of the transaction

Purchase of 1p ordinary shares

c)

Price(s) and volume(s)

Price(s)	Volume(s)
468.25p	6,000

d)

Aggregated information

- Aggregated volume

- Price

6,000 1p ordinary shares

468.25p per share

e)

Date of the transaction

9 December 2025

f)

Place of the transaction

XLON - London Stock Exchange

For further information:

Chemring Group PLC
Sarah Ellard	Group Legal Director & Company Secretary	+44 (0)7710 553757

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFFRFFLAIIE